Could IBD medications during pregnancy shape a Child's development?

NCT ID NCT00904878

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study follows pregnant women with inflammatory bowel disease (IBD) and their children for up to four years after birth. Researchers want to see whether the mother's disease activity or use of immunosuppressant or biologic medications affects pregnancy outcomes or the child's development. By comparing these children to those of mothers without IBD, the study aims to uncover any potential risks and help guide safer treatment decisions during pregnancy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
This research could help doctors better understand how inflammatory bowel disease and its treatments during pregnancy might affect a child's development, potentially guiding safer medication choices for expectant mothers.
What could go wrong
This is an observational study, so it can show links but not prove cause and effect. Results may take years to emerge, and many factors beyond IBD could influence child development.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Please Contact Jessica Lim For Further Information Regarding Other Sites' Locations

    RECRUITING

    San Francisco, California, 94115, United States

  • University of California San Francisco

    RECRUITING

    San Francisco, California, 94115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.